ISRCTN46268487
Completed
未知
A randomised, double blind, placebo-controlled study of the effects of Dehydroepiandrosterone (DHEA) replacement on vascular function in patients with primary and secondary adrenal insufficiency
Cardiff University (UK)0 sites40 target enrollmentJune 10, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Cardiff University (UK)
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
2009 results on http://www.ncbi.nlm.nih.gov/pubmed/19318448
Investigators
Eligibility Criteria
Inclusion Criteria
- •Individuals with at least a 4 year history of primary adrenal insufficiency and those with secondary adrenal insufficiency as a result of pituitary surgery for a non\-functioning pituitary tumour who did not receive radiotherapy and who are on stable doses of full hormone replacement including growth hormone.
Exclusion Criteria
- •Not provided at time of registration
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A randomised, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexateISRCTN49455679Academic Medical Center (AMC) (The Netherlands)191
Completed
Phase 2
A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced Non-Small Cell Lung Cancer (NSCLC)on-small cell lung cancerCancerMalignant neoplasm of lungISRCTN77341241Sponsor not defined - Record supplied by London Lung Cancer Group722
Completed
Not Applicable
A multicentre, double blind, placebo controlled, randomised trial to evaluate the effectiveness of a one-day versus seven-day regimen of nitrofurantoin for the treatment of asymptomatic bacteriuria in pregnancyAsymptomatic Bacteriuria (ASB)Infections and InfestationsBacteriuriaISRCTN11966080World Health Organization (WHO) (Switzerland)778
Completed
Not Applicable
Studying the impact of Lorazepam on approach/avoidance behaviour in healthy individualsISRCTN12590498Psychiatric University Hospital (Psychiatrische Universitätsklinik) Zürich (PUK ZH)60
Completed
Phase 3
A phase III randomised, double blind, placebo controlled trial of carboplatin/etoposide with or without thalidomide in small cell lung cancerSmall cell lung cancerCancerMalignant neoplasm of bronchus or lungISRCTN16174527Sponsor not defined - Record supplied by London Lung Cancer Group724